Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial-Reference-Cited by-同舟云学术

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

Published:2023-04 Issue:4 Volume:8 Page:356-367
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Gerard Jean-Pierre,Barbet Nicolas,Schiappa Renaud,Magné Nicolas,Martel Isabelle,Mineur Laurent,Deberne Mélanie,Zilli Thomas,Dhadda Amandeep,Myint Arthur Sun

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Ann Oncol,2018

2. Recurrence and survival after total mesorectal excision for rectal cancer;Heald;Lancet,1986

3. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Benson;J Natl Compr Canc Netw,2021

4. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med,2004

5. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control;Habr-Gama;Int J Radiat Oncol Biol Phys,2014

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer;Radiotherapy and Oncology;2024-10

2. Efficacy and safety of MR-guided adaptive simultaneous integrated boost radiotherapy to primary lesions and positive lymph nodes in the neoadjuvant treatment of locally advanced rectal cancer: a randomized controlled phase III trial;Radiation Oncology;2024-09-12

3. Watch and Wait is Changing: We Need to Change How We Count Costs;Annals of Surgical Oncology;2024-09-02

4. Dosimetry and Monte Carlo modelling of the Papillon+ contact X-ray brachytherapy device;Brachytherapy;2024-09

5. Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review;Cancer Treatment Reviews;2024-09